VEGFA and neoplasm: Notably, the particular doses of resveratrol that markedly reduced red blood cells in both OVCAR-8 and SKOV-3 (Figure 7) did not concurrently decrease the levels of VEGF, as determined through immunohistological staining in the CAM tumour.